Austedo Prior Authorization: Key Criteria Health Plans May Use
Required Clinical Documentation and Prior Treatment History
Health plans commonly list specific documentation items they expect to see when reviewing a request. These items often include a concise diagnostic summary, relevant exam findings, and baseline severity measures. Plans may also request copies of recent clinical notes that show the decision-making process for selecting the requested therapy. Where pre-authorization forms are used, completing required fields and attaching supporting documents may facilitate adjudication. Administrative completeness—clear date stamps, prescriber signatures, and precise medication lists—can affect processing times.
Prior treatment history is a frequent component of criteria language. Plans may ask for documentation of prior pharmacologic trials, reasons for discontinuation, or contraindications that preclude certain alternatives. Where step therapy is part of a plan’s policy, documentation of trials with specified agents or classes may be necessary. In some cases, documented intolerance, adverse events, or clinically justified contraindications may substitute for failed trials. The format for presenting prior treatment history can vary; some payers accept a concise medication history table, while others prefer narrative explanations tied to clinical notes.
Contraindications and potential drug interactions are elements that plans often review for safety considerations. Documentation that lists current medications, known allergies, relevant lab values, or other clinician-identified risks may be requested. For agents metabolized by specific pathways or with known interaction profiles, plans may expect evidence that prescribers considered interactions and adjusted management accordingly. These elements are typically handled as part of the clinical justification packet rather than as stand-alone disqualifiers in many policies.
Prescriber requirements may be articulated in policy language and can include specialty, board certification, or documented experience in managing the condition. Some plans permit general practitioners to initiate therapy if a documented specialist consultation has occurred, while others prefer initial prescriptions to originate from a specialist. Including clear prescriber identifiers, credentials, and a concise clinical rationale that demonstrates relevant experience may help align the submission with plan expectations. The next page examines baseline assessments and initial authorization considerations.